Forschung & Information
Wissenschaftliche Laufbahn
- 2012 Habilitation und Erlangung der Venia Docendi für das Fach Dermatologie und Venerologie
- 2009 Wissenschaftliche Mitarbeiterin und Lehrtätigkeit an der Univ. Klinik für Dermatologie und Venerologie, Medizinische Universität Graz
- 2009 Lehre an der Donau-Universität Krems
- 2004 -2009 Ausbildung zur Fachärztin an der Univ. Klinik für Dermatologie und Venerologie Graz, Medizinische Universität Graz. Facharztprüfung: 06.06.2008
- 2004 -2006 Postgraduales Studium der Telemedizin, FH Joanneum Graz. Sponsion zum Master of Science of Telemedicine am 30.06.2006
- 2002 -2009 Turnus/Gegenfächer: Universitätsklinik an der TU Dresden, Unfallkrankenhaus Salzburg, Medizinische Universität Graz
- 2002 -2002 Wissenschaftliche Mitarbeiterin an der Abteilung für Dermatologie und Venerologie, Wilhelminenspital, Wien
- 2001 -2002 Wissenschaftliche Mitarbeiterin an der Abteilung für Pädiatrie, Universitätsklinik Wien (Chromosomenlabor)
- 2001 -2002 Wissenschaftliche Mitarbeiterin der Wiener Schlaganfalldatenbank und Mitglied der Vienna stroke study group, Abteilung für Neurologie, Universitätsklinik Wien
- 1995 -2001 Studium der Humanmedizin. Promotion zum Doktor der gesamten Heilkunde am 21.03.200
Auszeichnungen
- 2011 Hans-Weitgasser-Preis (Erstautor), Wissenschaftliche Vereinigung der Steirischen Dermatologen
- 2009 Kyrle Reisestipendium der Österreichischen Gesellschaft für Dermatologie und Venerologie
Publikationen
CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study
Serum levels of the IFN-regulated cytokine CXCL13 have been found to correlate with SLEDAI and renal involvement in systemic lupus erythematosus. This study investigates whether CXCL13 can also be a marker of disease activity in [...]
Cyclosporine Reduces Sclerosis in Morphea: A Retrospective Study in 12 Patients and a Literature Review
BACKGROUND: The treatment of severe morphea is challenging, and treatment experience concerning the use of immunosuppressive agents for this condition is limited. OBJECTIVE: The purpose of this study is to analyze the use of cyclosporine, [...]
Mobile dermatology helping patients control high need-acne: a randomized controlled trial
BACKGROUND: Acne is an important health issue with a major psychological impact in addition to the physical problems it causes. OBJECTIVES: To investigate the superiority of mobile teledermatology in the care of patients with high‐need [...]
Teledermatology for skin cancer prevention: an experience on 690 Austrian patients
BACKGROUND: Recent studies investigated the value of teledermatology (TD) as a valid tool for a dermatologist-directed triage systems. OBJECTIVE: To investigate the feasibility of a store-and-forward TD triage system in a large number of patients. [...]
Mobile Teledermatology in Sub-Saharan Africa
In developing countries, such as Uganda, skin problems are among the most common ailments seen in primary healthcare settings (1). Due to the dire lack of trained dermatologists, the vast majority of patients with skin [...]
Patient acceptance and diagnostic utility of automated digital image analysis of pigmented skin lesions
BACKGROUND: Computerized analysis of pigmented skin lesions may help to increase diagnostic accuracy for melanoma, help to avoid unnecessary procedures and reduce health care costs. OBJECTIVES: We evaluated both the patient acceptance and diagnostic utility [...]
Präsentationen
Second opinion teleconsulting for the screening of skin cancer in Austria
TeleDerm 2010; -3rd World Congress of TeleDermatology; OCT 28-30, 2010; Amsterdam, THE NETHERLANDS. [Oral Communication]
Usability and acceptance of a mobile patient-administered skin cancer survey instrument for a hospital-based registry
TeleDerm 2010; -3rd World Congress of TeleDermatology; OCT 28-30, 2010; Amsterdam, THE NETHERLANDS. [Oral Communication]
Rosacea in and out Pregnancy – New Insights into Its Endocrinologic Background
Abstract CD-ROM2010; -7th EADV Spring Symposium ; MAY 13-16, 2010; Cavtat, CROATIA. [Oral Communication]
Erythema nodosum in pregnancy: Etiology, fetal outcome, and therapeutic considerations
J AMER ACAD DERMATOL. J AMER ACAD DERMATOL. 2010; 62(3):AB38-AB38.-68th Annual Meeting der American Academy of Dermatology; MAR 5-9; Miami, FL, USA. [Poster]
Erythema nodosum in pregnancy: Etiology, fetal outcome, and therapeutic considerations
J AMER ACAD DERMATOL 2010; 62(3):AB38-AB38.-68th Annual Meeting der American Academy of Dermatology; MAR 5-9; Miami, FL, USA.
Efficacy and safety of cyclosporine in severe localized scleroderma.
-. 2009; -18th Congress of the European Academy of Dermatology and Venerology; OCT 7-10, 2009; Berlin, GERMANY. [Poster]